Prognostic Value of Follow-up Mean Pulmonary Arterial Pressure and Pulmonary Vascular Resistance in Patients With Pulmonary Arterial Hypertension Reaching a Low-Risk Profile

作者
Francesco Cennerazzo,Fabio Dardi,Alberto Ballerini,M Salvi,Francesco Donato,Massimiliano Palazzini,Alessandra Manes,Nazzareno Galiè
出处
期刊:American Journal of Respiratory and Critical Care Medicine [American Thoracic Society]
卷期号:211 (Supplement_1): A4333-A4333
标识
DOI:10.1164/ajrccm.2025.211.abstracts.a4333
摘要

Abstract Background: Hemodynamic variables such as right atrial pressure, cardiac index (CI), stroke volume index (SVI), and mixed venous oxygen saturation have consistently been associated with survival in pulmonary arterial hypertension (PAH). New PAH treatments are, however, able to improve short-term outcome reducing mean pulmonary arterial pressure (mPAP) and pulmonary vascular resistance (PVR) without increasing CI or SVI. The prognostic role of a mPAP <35 mmHg at follow-up and PVR values <5 WU in prevalent patients have been described. Objective: The aim of this work was to define the incremental prognostic role of a mPAP <35 mmHg and PVR <5 WU in patients with idiopathic, hereditary, drug-induced PAH (I/H/D-PAH) and PAH associated with connective tissue disease (CTD-PAH) or congenital heart disease (CHD-PAH) reaching a low-risk profile at follow-up after first-line treatment strategy. Methods: treatment naïve PAH patients were assessed at 1st follow-up (3-6 months after starting PAH-specific therapy; 1st F-UP) with 6-minute walk distance (6MWD), World Health Organization functional class (WHO-FC), brain natriuretic peptide (BNP)/NT-proBNP and right heart catheterization. Risk was assessed according to COMPERA 1.0, FPHR-invasive, Bologna and COMPERA 2.0 risk tools. The primary outcome was all-cause death and a combined endpoint of all cause death + need of treatment escalation. Analyses were performed using Cox regression method in patients reaching a low-risk at 1st F-UP. Data are expressed as median (IQR). Results: 794 patients with PAH were enrolled (54% I/H/D, 28% CTD, 18% CHD) and 706 have a complete re-evaluation 4 (3-6) months after starting first-line treatment. Death occurred in 54% of patients over a median follow-up duration of 5.8 (2.4-11) years. Univariate analyses for all-cause death in patients reaching a low-risk profile at 1st F-UP are shown in Table 1. Univariate analyses for all cause death + need of treatment escalation, together with the initial treatment strategy and the median time from 1st F-UP to death/need of treatment escalation in patients reaching a low-risk profile at 1st F-UP are shown in Table 2. Conclusion: mPAP <35 mmHg and PVR <5 WU are not of incremental prognostic value for all-cause death in patients reaching a low-risk profile at 1st F-UP after first-line treatment strategy but predict the need of future treatment escalation (after a median time >3 years).

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
明年完成签到,获得积分10
刚刚
刚刚
研友_VZG7GZ的应助被galioo3000采纳,获得10
刚刚
Mae完成签到 ,获得积分10
刚刚
1秒前
Ceremony1718完成签到,获得积分10
1秒前
墨扬完成签到,获得积分10
1秒前
1秒前
所所的应助被小王快毕业采纳,获得10
1秒前
长大完成签到,获得积分10
2秒前
xinxin完成签到,获得积分20
3秒前
mmm完成签到 ,获得积分10
3秒前
芭乐发布了新的文献求助10
3秒前
zzx发布了新的文献求助10
4秒前
zzzzz完成签到,获得积分10
4秒前
蜗牛也是牛完成签到,获得积分10
4秒前
优美元枫完成签到,获得积分10
4秒前
Dilmma完成签到,获得积分10
4秒前
Lily完成签到,获得积分10
4秒前
冰冰完成签到,获得积分10
5秒前
李爱国的应助被skmksd采纳,获得10
5秒前
splemeth完成签到,获得积分10
5秒前
淡定的黑夜完成签到 ,获得积分10
5秒前
火星上的铃铛完成签到,获得积分10
5秒前
levitt233完成签到,获得积分10
6秒前
从容宛筠完成签到,获得积分10
6秒前
研友_ZG4ml8发布了新的文献求助10
7秒前
健康的可仁完成签到,获得积分10
7秒前
cecily完成签到,获得积分10
7秒前
里奥完成签到,获得积分10
8秒前
8秒前
univ完成签到,获得积分10
8秒前
颖颖完成签到,获得积分10
8秒前
dd完成签到,获得积分20
8秒前
奋斗以松完成签到,获得积分10
8秒前
curry完成签到,获得积分10
10秒前
少女闰土完成签到,获得积分20
11秒前
羽纱珏完成签到,获得积分10
11秒前
11秒前
milan完成签到 ,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180146
求助须知:如何正确求助?哪些是违规求助? 9570319
关于积分的说明 21809739
捐赠科研通 7776294
什么是DOI,文献DOI怎么找? 3433266
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479039